Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in CMMB — Chemomab Therapeutics Ltd.

CIK 1115418 BOSTON, MA
Back to CMMB Full portfolio

Position in CMMB

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$49,456
+$20,622 QoQ
Shares Held
30,529
+66.2% QoQ
Ownership
0.417%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 13 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CMMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. CMMB ranks #294 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in CMMB

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $49,456 30,529
2026-03-31 $28,834 18,366
2025-12-31 $29,462 17,856
2025-09-30 $24,998 9,505
2025-06-30 $46,255 39,875
2025-03-31 $25,995 23,849
2024-12-31 $43,092 23,808
2024-09-30 $43,289 27,573
2024-06-30 $18,127 19,877
2024-03-31 $14,510 18,627
2023-12-31 $9,499 18,627
2023-09-30 $2,544 2,843
2023-06-30 $3,951 3,005